EXHIBIT 11
CYTOCLONAL PHARMACEUTICS INC.
COMPUTATION OF NET (LOSS) PER COMMON SHARE
Year Ended December 31,
-----------------------------------------
1998 1997 1996
----------- ----------- -----------
Net (loss) $(2,728,000) $(3,252,000) $(2,890,000)
Add cumulative preferred dividend (187,000) (234,000) (307,000)
----------- ----------- -----------
NET (LOSS) USED FOR COMPUTATION $(2,915,000) (3,486,000) $(3,197,000)
Weighted average number of common shares
outstanding - basic and diluted $ 9,742,000 $ 8,268,000 $ 7,640,000
----------- ----------- -----------
Net (loss) per common share - basic and diluted $ (0.30) $ (0.42) $ (0.46)